BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 7, 2003
View Archived Issues
SBIR grant to fund investigation of Triapine's antiviral activity
Read More
BMS obtains license to Elan NanoCrystal technology
Read More
ViroPharma awarded SBIR grants to support biodefense effects
Read More
Avecia awarded anthrax vaccine contract by NIAID
Read More
Antiinflammatory effects of Ono-6126 in healthy volunteers
Read More
Potential benefits reported for the anticonvulsant vigabatrin in cocaine addiction
Read More
Improved lung function in asthmatics after treatment with roflumilast
Read More
Pregabalin in generalized anxiety disorder
Read More
New MMP inhibitors and their use reported by British Biotech and Serono researchers
Read More
Novel lipase inhibitors prepared and tested by Aventis scientists
Read More
Two series of antibacterial oxazolidinones with decreased MAO activity presented by AstraZeneca
Read More
Pharmacia (now Pfizer) claims new IKK-2 inhibitors for cancer and inflammation
Read More
Pfizer team identifies new glycogen phosphorylase inhibitors for diabetes and related disorders
Read More
New xanthine oxidase inhibitors described in Fuji Yakuhin patent
Read More
Actelion to acquire Axovan, obtaining rights to clazosentan
Read More
Barr to acquire Plan B emergency contraceptive
Read More
Chiron gains certain development and commercialization rights to Cubicin
Read More
Pivotal ocinaplon trial on hold pending additional safety information
Read More
Orion to withdraw German filing for Simdax and resubmit at later date
Read More
6-Aminouracil DNA polymerase IIIC inhibitors as new antibacterial agents
Read More
Hybrid antibacterial agents with dual oxazolidinone and quinolone properties
Read More
Chiron designs potent ketolide antibacterial agents
Read More
VIC-200603: a ramoplanin derivative with good local tolerability following systemic administration
Read More
Inhaled AWD-12-281 exerts potent bronchodilating effects in animal model of asthma
Read More
